ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were m...

Full description

Saved in:
Bibliographic Details
Published inJournal of veterinary internal medicine Vol. 33; no. 3; pp. 1127 - 1140
Main Authors Keene, Bruce W., Atkins, Clarke E., Bonagura, John D., Fox, Philip R., Häggström, Jens, Fuentes, Virginia Luis, Oyama, Mark A., Rush, John E., Stepien, Rebecca, Uechi, Masami
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.05.2019
Wiley
Subjects
Animals
canine
Cardiac arrhythmia
Cardiology
Cardiovascular disease
Cardiovascular diseases
Catheters
Clinical Science
Clinical trials
congestive heart failure
Consensus Statement
Consensus Statements
Coronary artery disease
Diagnosis
Dog Diseases - diagnosis
Dog Diseases - therapy
Dogs
evidence‐based treatment
Guidelines
Heart diseases
Heart failure
Heart Failure - diagnosis
Heart Failure - therapy
Heart Failure - veterinary
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - therapy
Hypertension, Pulmonary - veterinary
Klinisk vetenskap
Medical treatment
mitral
Mitral valve
Mitral Valve Insufficiency - diagnosis
Mitral Valve Insufficiency - therapy
Mitral Valve Insufficiency - veterinary
Quality
Rheumatic heart disease
evidence-based treatment
congestive heart failure
canine
mitral
Online AccessGet full text

Cover

More Information
Summary:This report, issued by the ACVIM Specialty of Cardiology consensus panel, revises guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD, also known as endocardiosis and degenerative or chronic valvular heart disease) in dogs, originally published in 2009. Updates were made to diagnostic, as well as medical, surgical, and dietary treatment recommendations. The strength of these recommendations was based on both the quantity and quality of available evidence supporting diagnostic and therapeutic decisions. Management of MMVD before the onset of clinical signs of heart failure has changed substantially compared with the 2009 guidelines, and new strategies to diagnose and treat advanced heart failure and pulmonary hypertension are reviewed.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-1
ObjectType-Feature-3
content type line 23
Consensus Statements of the American College of Veterinary Internal Medicine (ACVIM) provide the veterinary community with up‐to‐date information on the pathophysiology, diagnosis, and treatment of clinically important animal diseases. The ACVIM Board of Regents oversees selection of relevant topics, identification of panel members with the expertise to draft the statements, and other aspects of assuring the integrity of the process. The statements are derived from evidence‐based medicine whenever possible and the panel offers interpretive comments when such evidence is inadequate or contradictory. A draft is prepared by the panel, followed by solicitation of input by the ACVIM membership which may be incorporated into the statement. It is then submitted to the Journal of Veterinary Internal Medicine, where it is edited prior to publication. The authors are solely responsible for the content of the statements.
ISSN:0891-6640
1939-1676
1939-1676
DOI:10.1111/jvim.15488